Schizophrenia

Assessment and treatment selection for "revolving door" inpatients with schizophrenia.

Weiden P, Glazer W. Assessment and treatment selection for "revolving door" inpatients with schizophrenia. Psychiatr Q. 1997;68(4):377-92. PubMed PMID: 9355136.

Overview of partial compliance.

Marder SR. Overview of partial compliance. J Clin Psychiatry. 2003;64 Suppl 16:3-9. PubMed PMID: 14680412.

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.

Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Res. 2006;86(1-3):15-22. DOI: 10.1016/j.schres.2006.06.026. PubMed PMID: 16884895.

Neuroinflammation versus decreased Zif268 mRNA expression as causal mediators of decreased GAD67 mRNA expression within dorsolateral prefrontal cortex in schizophrenia.

Pearlman DM, Najjar S. Neuroinflammation versus decreased Zif268 mRNA expression as causal mediators of decreased GAD67 mRNA expression within dorsolateral prefrontal cortex in schizophrenia. Am J Psychiatry. 2014;171(10):1117-8. DOI: 10.1176/appi.ajp.2014.14060701. PubMed PMID: 25272348.

Response to Pearlman and Najjar.

Kimoto S, Lewis DA. Response to Pearlman and Najjar. Am J Psychiatry. 2014;171(10):1118-9. DOI: 10.1176/appi.ajp.2014.14060701r. PubMed PMID: 25272349.

An oversimplification of psychosis, its treatment, and its outcomes?

Peters E. An oversimplification of psychosis, its treatment, and its outcomes?. Br J Psychiatry. 2014;205(2):159-60. DOI: 10.1192/bjp.205.2.159a. PubMed PMID: 25252324.

Authors' reply.

McKenna PJ, Radua J, Laws KR, Jauhar S. Authors' reply. Br J Psychiatry. 2014;205(2):160-1. DOI: 10.1192/bjp.205.2.160. PubMed PMID: 25252325.

Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies.

Arnedo J, Svrakic DM, Del Val C, Romero-Zaliz R, Hernández-Cuervo H, Fanous AH, et al.. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry. 2015;172(2):139-53. DOI: 10.1176/appi.ajp.2014.14040435. PubMed PMID: 25219520.

Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?

Lavoie J, Hébert M, Beaulieu J-M. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?. Biol Psychiatry. 2015;77(3):e15-7. DOI: 10.1016/j.biopsych.2014.07.024. PubMed PMID: 25193244.

Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.

Xiong P, Zeng Y, Wu Q, Han Huang DX, Zainal H, Xu X, et al. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration. J Clin Psychiatry. 2014;75(8):e794-801. DOI: 10.4088/JCP.13m08772. PubMed PMID: 25191916.